Covered recipient · General Payments record
LAUREN MCGRAW
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,526.00
- Reported across 109 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $269.74 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $77.01 | 4 |
| Lilly USA, LLC | $47.90 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $40.01 | 2 |
| ABBVIE INC. | $35.24 | 2 |
| GlaxoSmithKline, LLC. | $33.25 | 2 |
| Acerta Pharma LLC | $19.36 | 1 |
| Antares Pharma, Inc. | $16.97 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.23 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105003229 | CMS |
| ABBVIE INC. | $20.01 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105003231 | CMS |
| Antares Pharma, Inc. | $16.97 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146473130 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.36 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105858782 | CMS |
| GlaxoSmithKline, LLC. | $14.22 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116253215 | CMS |
| GlaxoSmithKline, LLC. | $19.03 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116732762 | CMS |
| Lilly USA, LLC | $15.16 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135119735 | CMS |
| Lilly USA, LLC | $16.59 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135126898 | CMS |
| Lilly USA, LLC | $16.15 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135084752 | CMS |
| Novartis Pharmaceuticals Corporation | $17.77 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087117206 | CMS |
| Novartis Pharmaceuticals Corporation | $22.24 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087117210 | CMS |
| Novo Nordisk Inc | $17.54 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097599343 | CMS |
| Novo Nordisk Inc | $20.37 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097391916 | CMS |
| Novo Nordisk Inc | $18.80 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097713143 | CMS |
| Novo Nordisk Inc | $20.30 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096693828 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.